Jue Wang

Jue Wang

Auto-generated profile, based on publicly available information

Jue Wang

Department of Cardiology (F.L., L.Z., Y.Z., S.W., J.W., X.K., X.G., L.H., S.X., Chao Jiang, X. Li, J.Z., X. Liu, N.Z., S.L., Chenxi Jiang, R.T., S.Z., C.S., D.L., J.D., C.M.), Beijing Anzhen Hospital, Capital Medical University, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2023 in Hypertension
Verified
Journal Article
Open access
JWJue Wang
Jue Wang
CJChao Jiang
Chao Jiang
SLSitong Li
Sitong Li
ZWZhiyan Wang
Zhiyan Wang
YWYufeng Wang
Yufeng Wang
CMChangsheng Ma
Changsheng Ma
BACKGROUND: Systolic blood pressure (SBP) time in target range (TTR) indicates the mean value, exposure time, and variability in blood pressure over time. The prognostic value of SBP TTR for incident atrial fibrillation (AF) in patients with hypertension is unclear. METHODS: We performed a post hoc analysis of SPRINT (Systolic Blood Pressure Intervention Trial), a randomized controlled trial comparing intensive (<120 mm Hg) and standard (<140 mm Hg) SBP interventions in participants with hypertension. SBP target ranges for intensive and standard arms were defined as 110 to 130 and 120 to 140 mm Hg, respectively. TTR was calculated by linear interpolation method using SBP from months 0 to 3. We used Cox proportional regression models to assess the association of SBP TTR with incident AF. RESULTS: Among 7939 participants included in this analysis, 187 incident AF cases occurred during follow-up. After multivariable adjustment, a 10% increase in SBP TTR was independently associated with a 7% lower risk of incident AF (hazard ratio, 0.93 [95% CI, 0.88–0.97]; P =0.003). The restricted spline curve depicted a linear and inverse relationship between SBP TTR and incident AF. Sensitivity analyses generated consistent results when calculating TTR over a longer period or setting target range as 110 to 140 mm Hg for the whole population. CONCLUSIONS: Higher SBP TTR independently predicts a lower risk of incident AF. Efforts to attain SBP within 110 to 140 mm Hg over time may be an effective strategy to prevent AF. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01206062.

13 May 2024 in JACC
Verified
Journal Article
Closed access
MLMingxiao Li
Mingxiao Li
LRLan Ren
Lan Ren
LHLiu He
Liu He
YLYiwei Lai
Yiwei Lai
JWJue Wang
Jue Wang
CMChangsheng Ma
Changsheng Ma

7 July 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
ZWZhen Wang
Zhen Wang
YLYiwei Lai
Yiwei Lai
YWYufeng Wang
Yufeng Wang
JWJue Wang
Jue Wang
CJChao Jiang
Chao Jiang
CMChangsheng Ma
Changsheng Ma
After radiofrequency catheter ablation (RFCA) of atrial fibrillation (AF), the effect of very-early (within 48 h) symptomatic recurrence (VESR) on late (after 3 months of RFCA) recurrence (LR) has been seldomly reported. We aimed to explore the relationship between VESR and LR among post-RFCA patients. This was a single-centre prospective cohort study that enrolled 6887 AF patients who received the first RFCA procedure from June 2018 to December 2021 at Beijing Anzhen Hospital. Patients were divided into four groups based on VESR and early (from 48 h to 3 months after RFCA) recurrence (ER): Group A (no VESR, no ER); Group B (VESR but no ER); Group C (ER but no VESR); and Group D (both VESR and ER). Three hundred and thirty (4.79%) patients experienced VESR (Groups B and D). With an average follow-up of 14.7 months after grouping, the Kaplan–Meier curve showed that LR risk in VESR patients was higher than in other patients (log-rank, P < 0.001), and the difference was significant in both paroxysmal (log-rank, P < 0.001) and persistent (log-rank, P < 0.001) AF patients (P for interaction = 0.118). In multivariate analysis, Groups B, C, and D were associated with a 2.161-, 5.409-, and 7.401-fold increase in the risk of LR, respectively. What is more, compared with Group A, VESR-atrial tachycardia and VESR-AF were related to a 3.467- and 5.564-fold LR risk, respectively. In VESR patients, classification based on ER and VESR modes improved the prediction potential of LR risk. Very-early symptomatic recurrence is associated with an increased risk of LR.

6 May 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
SLSitong Li
Sitong Li
JZJingrui Zhang
Jingrui Zhang
SZSong Zuo
Song Zuo
JWJue Wang
Jue Wang
YLYiwei Lai
Yiwei Lai
CMChangsheng Ma
Changsheng Ma
Background: Atrial arrhythmia recurrence after atrial fibrillation (AF) catheter ablation is conventionally assessed as a binary end point. However, the prognostic value of recurrence patterns is less studied. Methods and Results: This study included patients undergoing catheter ablation from the multicenter China Atrial Fibrillation Registry study (2011–2022). Postablation AF patterns within 1 year were categorized as nonrecurrence, paroxysmal AF recurrence, or persistent AF (PersAF) recurrence. Cardiovascular outcomes included cardiovascular death, thromboembolism, and cardiovascular hospitalization. Cox proportional models with landmark analysis were used to assess the relationship between recurrence patterns and outcomes. Sensitivity analyses were conducted using Fine‐Gray models, considering death unrelated to the outcomes as the competing risk and evaluating 2‐year recurrence patterns. Among 13 811 patients (mean age, 60.5±10.8 years; 66.1% men), those with preablation PersAF, prior stroke/transient ischemic attack/systemic embolism, and increased left atrial diameter were more likely to develop PersAF postablation. Compared with nonrecurrence, PersAF recurrence was associated with higher risks of cardiovascular death (hazard ratio [HR], 2.03 [95% CI, 1.20–3.43]; P =0.009), thromboembolism (HR, 1.50 [95% CI, 1.09–2.06]; P =0.012), and cardiovascular hospitalization (HR, 1.74 [95% CI, 1.56–1.94]; P <0.001) during a median follow‐up of 3.02 years (interquartile range, 1.44–5.03 years), while paroxysmal AF recurrence was only significantly associated with an increased risk of cardiovascular hospitalization (HR, 1.98 [95% CI, 1.83–2.14], P <0.001). Sensitivity analyses yielded consistent results. Conclusions: Postablation PersAF recurrence was associated with significantly higher risks of cardiovascular death and thromboembolism, compared with paroxysmal AF recurrence and nonrecurrence, indicating the prognostic importance of recurrence patterns. Registration: URL: www.chictr.org.cn/ ; unique identifier: ChiCTR‐OCH‐13003729.

11 June 2026 in JACC: Clinical Electrophysiology
Verified
Journal Article
Closed access
SZSong Zuo
Song Zuo
LZLe Zhou
Le Zhou
HFHan Feng
Han Feng
CMChristian Massad
Christian Massad
MKMichel Abou Khalil
Michel Abou Khalil
CMChangsheng Ma
Changsheng Ma

20 July 2025 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
ZWZhixian Wang
Zhixian Wang
JWJue Wang
Jue Wang
LHLiu He
Liu He
CJChao Jiang
Chao Jiang
YWYufeng Wang
Yufeng Wang
CMChangsheng Ma
Changsheng Ma
Intensive systolic blood pressure (SBP) control reduces cardiovascular outcomes in hypertensive patients, but its effects in those with diabetes and prior stroke need further evidence. Among 4733 patients with elevated SBP enrolled in the ACCORD‐BP (Action to Control Cardiovascular Risk in Diabetes–Blood Pressure) trial, this post‐hoc analysis focused on 307 patients with type 2 diabetes and prior stroke to evaluate intensive versus standard SBP control. The primary outcome was major adverse cardiovascular events (MACE), a composite of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke. Inverse probability of treatment weighting (IPTW)‐adjusted Kaplan‐Meier and Cox regression analyses were performed with a 3‐year conditional landmark. Multivariable Cox regression models and overlap weighting models were constructed in sensitivity analysis. In landmark analysis at the 3‐year time point, intensive SBP control was associated with a significantly lower risk of MACE (hazard ratio [HR] 0.55, 95% CI, 0.32–0.95) using the IPTW Cox model. The associations remained consistent across multivariable Cox regression model (HR 0.53, 95% CI, 0.31–0.90) and overlap weighting model (HR 0.55, 95% CI, 0.32–0.94). Patients in the intensive SBP control group showed a trend toward lower recurrent stroke risk, though it was not statistically significant (HR 0.65, 95% CI, 0.30–1.37). Similar trends were observed in subgroup analyses. In conclusion, targeting an SBP below 120 mmHg in patients with diabetes and prior stroke is associated with a lower risk of major cardiovascular events without increasing the risk of recurrent stroke.Trial Registration: ClinicalTrials.gov identifier: NCT00000620